Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trospium Chloride vs Tamsulosin for Ureteral Stent Symptoms
NCT03709992Suspended
- Sponsor
- Mansoura University
- Start
- Dec 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trospium in ureteral stent syndrome (SRS) (2 arms), sponsored by Mansoura University. Primary endpoint: Ureteral Stent Symptoms Questionnaire at 14 days. Started Dec 2020; status: suspended.
02
Drugs
trospium
03
Conditions
ureteral stent syndrome (SRS)
Beyond the preview
Go deeper on NCT03709992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709992.